<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Unexplained weight loss / night sweats — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Unexplained weight loss / night sweats</h1>
        <div class="sub">Evidence summary (key statements + how they fit together) → DGRefHelp first draft (D&amp;G).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑12</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key decision points to build the page around</strong>
                <ul>
                  <li><strong>Don’t treat “weight loss / night sweats” as a single pathway.</strong> Use the <strong>associated symptom/exam finding</strong> to choose the correct site-specific cancer investigation/referral (NG12 symptom chapter is the fastest way to do this).</li>
                  <li><strong>Night sweats + weight loss + lymphadenopathy/splenomegaly</strong> are classic “B symptoms” for haematological malignancy; NG12 explicitly says to take fever/night sweats/weight loss into account when deciding suspected cancer referral for non‑Hodgkin’s lymphoma (and very urgent bloods for leukaemia patterns).</li>
                  <li><strong>If symptoms are non‑specific and don’t fit a single USC pathway</strong>: Scotland uses <strong>Rapid Cancer Diagnostic Services (RCDS)</strong> in some areas (or GP direct access CT where not available). Threshold commonly used: <strong>new unexplained unintentional weight loss ≥5% in 3 months</strong> (or strong clinical suspicion).</li>
                </ul>
              </div>

              <h4>1) NICE NG12 (symptom-led investigation/referral)</h4>
              <ul>
                <li>NG12 provides <strong>recommendations organised by symptom/findings</strong> and is designed for “starting from the symptom” when cancer site is unclear.</li>
                <li>Examples relevant to weight loss (from the symptom chapter):
                  <ul>
                    <li><strong>Upper abdominal pain + weight loss (≥55)</strong> → suspected cancer pathway referral for <strong>oesophageal/stomach</strong>.</li>
                    <li><strong>Abdominal pain + weight loss (≥60)</strong> → consider urgent direct access CT (or urgent USS if CT not available) for <strong>pancreatic</strong>.</li>
                    <li><strong>Abdominal pain with unexplained weight loss (≥40)</strong> → offer <strong>FIT</strong> for possible <strong>colorectal</strong>.</li>
                  </ul>
                </li>
                <li>NG12 also embeds “when still uncertain, consider specialist advice” and safety-netting recommendations.</li>
              </ul>

              <h4>2) NICE NG12 (haematology signals inside symptom chapter)</h4>
              <ul>
                <li><strong>Unexplained splenomegaly</strong> → consider suspected cancer pathway referral for <strong>non‑Hodgkin’s lymphoma</strong>; explicitly consider associated symptoms including <strong>fever, night sweats, shortness of breath, pruritus, weight loss</strong>.</li>
                <li><strong>Hepatosplenomegaly</strong> → consider a <strong>very urgent FBC (within 48 hours)</strong> for possible leukaemia (and escalate per results/clinical state).</li>
              </ul>

              <h4>3) Non-specific symptom pathways (Cancer Research UK summary of NHS Scotland RCDS criteria)</h4>
              <ul>
                <li>CRUK summarises the referral criteria used for rapid diagnostic pathways in Scotland: <strong>new unexplained unintentional weight loss (≥5% in 3 months or strong clinical suspicion)</strong>; and other new unexplained constitutional symptoms for ≥4 weeks (or less if significant concern).</li>
                <li>Where RCDS are not available, GP direct access CT is used in some areas (local arrangement).</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (drafting-site only)</strong>
                <ul>
                  <li>Confirm D&amp;G route for <strong>non-specific symptoms / RCDS</strong> (if available) vs <strong>direct access CT</strong> vs “most likely site” USC pathway.</li>
                  <li>Confirm the <strong>baseline “filter function” test set</strong> expected before NSS/RCDS referral (many pathways specify a standard bundle).</li>
                  <li>Confirm whether night sweats/weight loss with normal exam should go to <strong>medical</strong>, <strong>haematology</strong>, or NSS/RCDS in D&amp;G, and what urgency.</li>
                </ul>
              </div>

              <div class="small">This evidence summary is written for pathway design: it highlights only decision‑changing points and where local policy choices sit.</div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Unintentional weight loss&lt;/strong&gt; and/or &lt;strong&gt;night sweats&lt;/strong&gt; are non‑specific symptoms with a wide differential (malignancy, infection, endocrine/metabolic, inflammatory, medication/substance, mental health).&lt;/li&gt;
  &lt;li&gt;Key principle: use the &lt;strong&gt;associated symptoms/exam findings&lt;/strong&gt; to choose the correct &lt;strong&gt;site‑specific&lt;/strong&gt; investigation/referral pathway (rather than a single generic rule).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;B symptoms&lt;/strong&gt; (night sweats, fever, weight loss) with lymphadenopathy/splenomegaly raise concern for haematological malignancy.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Confirm the symptom&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Is weight loss &lt;strong&gt;unintentional&lt;/strong&gt;? quantify (kg and % over time; weigh now and compare prior weights if available).&lt;/li&gt;
      &lt;li&gt;Night sweats: severity (soaking clothes/bedding), frequency, duration; associated fever/rigors; exposures (TB), travel, HIV risk.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Red flags / same‑day&lt;/strong&gt;: haemodynamic instability, severe dehydration, sepsis features, new confusion, severe hypercalcaemia symptoms, suspected DKA, significant haemoptysis, GI bleed, rapidly progressive symptoms, or strong suspicion of malignancy with acute compromise.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Focused history/exam to “pick a site” (examples)&lt;/strong&gt;:
    &lt;ul&gt;
      &lt;li&gt;Upper GI: dysphagia, persistent vomiting, upper abdominal pain.&lt;/li&gt;
      &lt;li&gt;Lower GI: change in bowel habit, PR bleeding, abdominal pain.&lt;/li&gt;
      &lt;li&gt;Resp: cough, breathlessness, chest pain, haemoptysis.&lt;/li&gt;
      &lt;li&gt;GU: haematuria, LUTS.&lt;/li&gt;
      &lt;li&gt;Haematology: lymphadenopathy, splenomegaly, pruritus, recurrent infections, bruising.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Baseline tests (typical “filter function” bundle — local may vary)&lt;/strong&gt;:
    &lt;ul&gt;
      &lt;li&gt;FBC + film (if abnormal), CRP/ESR.&lt;/li&gt;
      &lt;li&gt;U&amp;amp;E/eGFR, LFTs, calcium, glucose/HbA1c.&lt;/li&gt;
      &lt;li&gt;TSH.&lt;/li&gt;
      &lt;li&gt;Ferritin/iron studies if anaemia suspected.&lt;/li&gt;
      &lt;li&gt;Urinalysis.&lt;/li&gt;
      &lt;li&gt;Chest X‑ray if respiratory symptoms or clinical concern (and per NG12 criteria).&lt;/li&gt;
      &lt;li&gt;Consider FIT if lower‑GI features/abdominal pain with weight loss (per NG12).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;If no emergency features&lt;/strong&gt;: complete baseline assessment/tests promptly, and arrange short‑interval review (e.g. 2–4 weeks) to reassess symptoms, weight trend and results.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Address reversible contributors&lt;/strong&gt; where clear (e.g. medication side effects, uncontrolled diabetes, hyperthyroidism symptoms) but do not delay investigation if clinical concern.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Safety‑net&lt;/strong&gt;: clear return instructions if rapid deterioration, new focal symptoms (e.g. dysphagia, haemoptysis, PR bleeding), persistent fever, or ongoing weight loss.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;p&gt;&lt;strong&gt;Pick the most likely pathway.&lt;/strong&gt; Use NG12 symptom‑based recommendations to choose site‑specific investigation/referral where possible.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Suspected cancer pathway (USC / 2WW)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Refer via the &lt;strong&gt;appropriate site‑specific&lt;/strong&gt; USC pathway when NG12 criteria are met (examples include dysphagia; upper abdominal pain with weight loss in older adults; persistent haemoptysis; persistent unexplained lymphadenopathy with B symptoms).&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Non‑specific symptoms pathway / RCDS (if available)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Consider NSS/RCDS if symptoms are concerning but do not fit a single site‑specific USC pathway.&lt;/li&gt;
  &lt;li&gt;Typical threshold used in Scotland: &lt;strong&gt;new unexplained unintentional weight loss ≥5% in 3 months&lt;/strong&gt; (or strong clinical suspicion), and/or other new unexplained constitutional symptoms.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Route (draft):&lt;/strong&gt; SCI Gateway → [local NSS/RCDS service name] OR GP direct access CT (where RCDS not available).&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Haematology / medical same‑day advice / urgent assessment&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;If &lt;strong&gt;lymphadenopathy/splenomegaly&lt;/strong&gt; with &lt;strong&gt;night sweats, fever, weight loss&lt;/strong&gt; or concerning blood results (anaemia, thrombocytopenia, very abnormal WCC) → urgent discussion/referral per local pathway.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;If weight is stable and an alternative benign explanation is clear and symptoms resolve, manage in primary care with routine follow‑up.&lt;/li&gt;
  &lt;li&gt;Do &lt;strong&gt;not&lt;/strong&gt; use NSS/RCDS as a default if a &lt;strong&gt;site‑specific&lt;/strong&gt; USC pathway clearly applies (use the site pathway).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;NICE NG12: Suspected cancer — recommendations organised by symptom and findings of primary care investigations. https://www.nice.org.uk/guidance/ng12/chapter/recommendations-organised-by-symptom-and-findings-of-primary-care-investigations (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;NICE NG12: Suspected cancer — recommendations organised by site of cancer (includes non‑site‑specific symptoms section). https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;Cancer Research UK: Guidelines and referral pathways in Scotland (non‑specific symptom pathways; RCDS; weight loss ≥5% in 3 months threshold). https://www.cancerresearchuk.org/health-professional/diagnosis/primary-care/managing-non-specific-symptoms-in-primary-care/guidelines-and-referral-pathways-in-scotland (retrieved 2026‑02‑12)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Unexplained weight loss / night sweats</h3>

              <h4>Background</h4>
              <ul>
                <li><strong>Unintentional weight loss</strong> and/or <strong>night sweats</strong> are non‑specific symptoms with a wide differential (malignancy, infection, endocrine/metabolic, inflammatory, medication/substance, mental health).</li>
                <li>Key principle: use the <strong>associated symptoms/exam findings</strong> to choose the correct <strong>site‑specific</strong> investigation/referral pathway (rather than a single generic rule).</li>
                <li><strong>B symptoms</strong> (night sweats, fever, weight loss) with lymphadenopathy/splenomegaly raise concern for haematological malignancy.</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>Confirm the symptom</strong>
                  <ul>
                    <li>Is weight loss <strong>unintentional</strong>? quantify (kg and % over time; weigh now and compare with prior weights if available).</li>
                    <li>Night sweats: severity (soaking clothes/bedding), frequency, duration; associated fever/rigors; exposures (TB), travel, HIV risk.</li>
                  </ul>
                </li>

                <li><strong>Red flags / same‑day:</strong> haemodynamic instability, severe dehydration, sepsis features, new confusion, severe hypercalcaemia symptoms, suspected DKA, significant haemoptysis, GI bleed, rapidly progressive symptoms, or strong suspicion of malignancy with acute compromise.</li>

                <li><strong>Focused history/exam to “pick a site” (examples)</strong>:
                  <ul>
                    <li>Upper GI: dysphagia, persistent vomiting, upper abdominal pain.</li>
                    <li>Lower GI: change in bowel habit, PR bleeding, abdominal pain.</li>
                    <li>Resp: cough, breathlessness, chest pain, haemoptysis.</li>
                    <li>GU: haematuria, LUTS.</li>
                    <li>Haematology: lymphadenopathy, splenomegaly, pruritus, recurrent infections, bruising.</li>
                  </ul>
                </li>

                <li><strong>Baseline tests (typical “filter function” bundle — local may vary):</strong>
                  <ul>
                    <li>FBC + film (if abnormal), CRP/ESR.</li>
                    <li>U&amp;E/eGFR, LFTs, calcium, glucose/HbA1c.</li>
                    <li>TSH.</li>
                    <li>Ferritin/iron studies if anaemia suspected.</li>
                    <li>Urinalysis.</li>
                    <li>Chest X‑ray if respiratory symptoms or clinical concern (and per NG12 criteria).</li>
                    <li>Consider FIT if lower‑GI features/abdominal pain with weight loss (per NG12).</li>
                  </ul>
                </li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li><strong>If no emergency features:</strong> complete baseline assessment/tests promptly, and arrange short‑interval review (e.g. 2–4 weeks) to reassess symptoms, weight trend and results.</li>
                <li><strong>Address reversible contributors</strong> where clear (e.g. medication side effects, uncontrolled diabetes, hyperthyroidism symptoms) but do not delay investigation if clinical concern.</li>
                <li><strong>Safety‑net:</strong> clear return instructions if rapid deterioration, new focal symptoms (e.g. dysphagia, haemoptysis, PR bleeding), persistent fever, or ongoing weight loss.</li>
              </ul>

              <h4>Who to refer</h4>
              <p class="small"><strong>Pick the most likely pathway.</strong> Use NG12 symptom‑based recommendations to choose site‑specific investigation/referral where possible.</p>

              <h4>Suspected cancer pathway (USC / 2WW)</h4>
              <ul>
                <li>Refer via the <strong>appropriate site‑specific</strong> USC pathway when NG12 criteria are met (examples include dysphagia; upper abdominal pain with weight loss in older adults; persistent haemoptysis; persistent unexplained lymphadenopathy with B symptoms).</li>
              </ul>

              <h4>Non‑specific symptoms pathway / RCDS (if available)</h4>
              <ul>
                <li>Consider NSS/RCDS if symptoms are concerning but do not fit a single site‑specific USC pathway.</li>
                <li>Typical threshold used in Scotland: <strong>new unexplained unintentional weight loss ≥5% in 3 months</strong> (or strong clinical suspicion), and/or other new unexplained constitutional symptoms.</li>
                <li><strong>Route (draft):</strong> SCI Gateway → [local NSS/RCDS service name] OR GP direct access CT (where RCDS not available).</li>
              </ul>

              <h4>Haematology / medical urgent assessment</h4>
              <ul>
                <li>If <strong>lymphadenopathy/splenomegaly</strong> with <strong>night sweats, fever, weight loss</strong> or concerning blood results (anaemia, thrombocytopenia, very abnormal WCC) → urgent discussion/referral per local pathway.</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>If weight is stable and an alternative benign explanation is clear and symptoms resolve, manage in primary care with routine follow‑up.</li>
                <li>Do <strong>not</strong> use NSS/RCDS as a default if a <strong>site‑specific</strong> USC pathway clearly applies (use the site pathway).</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm D&amp;G route for <strong>non-specific symptoms / RCDS</strong> (if available) vs <strong>direct access CT</strong> vs “most likely site” USC pathway.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm the <strong>baseline “filter function” test set</strong> expected before NSS/RCDS referral.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether night sweats/weight loss with normal exam should go to <strong>medical</strong>, <strong>haematology</strong>, or NSS/RCDS in D&amp;G, and what urgency.</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑12)</h3>
              <ol>
                <li>NICE NG12: Suspected cancer — recommendations organised by symptom and findings of primary care investigations. <a href="https://www.nice.org.uk/guidance/ng12/chapter/recommendations-organised-by-symptom-and-findings-of-primary-care-investigations">nice.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (includes non‑site‑specific symptoms section). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Cancer Research UK: Guidelines and referral pathways in Scotland (non‑specific symptom pathways; RCDS; weight loss ≥5% in 3 months threshold). <a href="https://www.cancerresearchuk.org/health-professional/diagnosis/primary-care/managing-non-specific-symptoms-in-primary-care/guidelines-and-referral-pathways-in-scotland">cancerresearchuk.org</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
